Dissection of the APCCdh1-Skp2 cascade in breast cancer
Takeo Fujita1, Weijun Liu, Hiroyoshi Doihara
1Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Purpose:
Skp2 is a subunit of the SCF ubiquitin protein ligase, which plays a vital role in the control of tumorigenesis via its regulation of G(1)-S transition. Deregulation of Skp2 in various types of cancers correlates with aggressive clinical behavior and poor prognosis. Recent studies suggest that cell cycle-dependent fluctuation of Skp2 is governed by APC(Cdh1), another important E3 ligase, thereby preventing premature entry into S phase. To assess the potential role of APC(Cdh1) in tumorigenesis through proteolysis of Skp2, we have dissected the APC(Cdh1)-Skp2 cascade.
Experimental Design:
We manipulated the APC(Cdh1)-Skp2 cascade and examined its cellular behavior using both breast cancer and normal breast epithelial cells. Furthermore, applying immunohistochemistry, we analyzed the clinicopathologic significance of these molecules in patients with breast cancer.
Results:
Analysis of tissue arrays indicated that the percentage of samples positive for Cdh1 in breast cancer was significantly lower compared with normal breast tissues (P=0.004). Conversely, the percentage of samples scored as positive for Skp2 in cancer was significantly higher than in normal tissues (P<0.001). Moreover, prognostic studies revealed that relatively high levels of Cdh1 are associated with survivability in patients with breast cancer. In addition, depletion of Cdh1 by small interfering RNA in normal breast cells resulted in increased cellular proliferation, whereas knockdown of Skp2 significantly suppressed growth in breast cancer cells.
Conclusions:
This study shows a correlation between Skp2 and APC(Cdh1) in breast cancer. Thus, Cdh1 may act as an important component in tumor suppression and could be considered as a novel biomarker in breast cancer.
Insights
The anaphase-promoting complex (APC/Cdh1) regulates Skp2, a protein crucial for cell cycle progression. Lower Cdh1 and higher Skp2 levels in breast cancer indicate poor prognosis, suggesting Cdh1 as a potential tumor suppressor and biomarker.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- Skp2, a subunit of the SCF ubiquitin ligase, is vital in controlling tumorigenesis by regulating the G(1)-S cell cycle transition.
- Deregulation of Skp2 is linked to aggressive clinical behavior and poor prognosis in various cancers.
- Recent studies suggest the anaphase-promoting complex (APC/Cdh1) governs Skp2 fluctuations, preventing premature S-phase entry.
Purpose of the Study:
- To investigate the role of the APC/Cdh1-Skp2 cascade in tumorigenesis.
- To assess the potential of APC/Cdh1 as a tumor suppressor through Skp2 proteolysis.
Main Methods:
- Manipulation of the APC/Cdh1-Skp2 cascade in breast cancer and normal breast epithelial cells.
- Examination of cellular behavior following cascade manipulation.
- Immunohistochemical analysis of APC/Cdh1 and Skp2 in breast cancer patient tissues.
Main Results:
- Breast cancer tissues showed significantly lower Cdh1 and higher Skp2 levels compared to normal tissues.
- Higher Cdh1 levels correlated with better survivability in breast cancer patients.
- Cdh1 depletion increased proliferation in normal cells, while Skp2 knockdown suppressed growth in cancer cells.
Conclusions:
- A significant correlation exists between Skp2 and APC/Cdh1 in breast cancer.
- APC/Cdh1 functions as a tumor suppressor by targeting Skp2.
- Cdh1 may serve as a novel biomarker for breast cancer prognosis.
Related Concept Videos
Anaphase Promoting Complex
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Restarting Stalled Replication Forks
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

